Search 

Silence Therapeutics is a leading RNAi company, developing highly innovative medicines with life-saving potential for patients with serious and rare diseases, based upon its proprietary technology platform in GalNAc conjugated siRNA.

The Company is in a strong position to maximise the potential of its IP and technology through collaborations and the advancement of internal programmes toward the clinic. Silence’s lead candidate SLN124 will move into clinical development in the coming year.

Strathos Pharma is a privately owned company group which is active within the following business fields:

Marketing and distribution of OTC brands in Germany, Switzerland and Austria with specific strengths

in the field of: Cough & Cold, Sinus, Respiratory and Allergy products (Siemens & CO: Emser®); herbal

(medicinal) teas and herbal products (Sidroga®) both in pharmacies and drug stores (Emsan®).

The company group´s annual turnover exceeds 55 Mio. EUR.

Strong sales and marketing structures in our target markets (Germany, Switzerland and Austria) with 50

sales representatives and about 8.000 permanent product displays (shop in shop system) in pharmacies

and key acount Management of Drugstores.

In-Licensing of products for extension of our OTC portfolio in Germany, Switzerland and Austria.

Main target areas for natural products (e.g. phyto medicine): Cough & Cold, Sinus, Respiratory, Allergy,

Sleep disorders, Mental Stress, CNS, Female Health, Male Health, Gastro - all regulatory pathways

(medicinal products, medical device, etc.)

Additionally substance based medical devices for all indications

Advanced development projects in the upper mentioned therapeutic categories - generic and innovative.